07 Jan 2001

Levopar® 62,5 (Levopar® 62,5 mg/-125 mg/-250 mg Kapseln) - Deutschland

Updated: 07 Jan 2001

Levopar® 62,5 mg | -125 mg | -250 mg

Morbus Parkinson, symptomat. Parkinson-Syndr. (ausgenommen medikamentös induzierte Parkins.-Syndr.)

Levopar® 62,5 Description, Presentation and Dosage

Levopar® 62,5 Description

Levopar® 62,5 Drug Class Description

Kombinationen

Levopar® 62,5 Drug Description

1 Kps. enth.: Levodopa 50 mg/100 mg/200 mg, Benserazid 12,5 mg/25 mg/50 mg.

Levopar® 62,5 Generic Name

Levopar® 62,5 mg/-125 mg/-250 mg Kapseln

Levopar® 62,5 Presentation

Levopar® 62,5 Presentation

Levopar® 62,5 mg/-125 mg/-250 mg

Levopar® 62,5 Manufacturer

Hexal/Neuro Hexal

Related Learning Zones

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

Symptomatic Asthma Knowledge Centre and CME

Symptomatic Asthma Knowledge Centre and CME

Focusing on the lack of symptomatic control in patients with asthma, the new Symptomatic Asthma Learning Zone, consisting of a Disease Awareness section and an RCGP-accredited CME, is free to access for all epgonline.org members, and has been designed to provide them with the information they need to effectively manage the symptoms of their patients with asthma.

Levopar® 62,5 Dosage

Levopar® 62,5 Adult Dosage

Lactose 82,35 mg/164,7 mg/329,4 mg, Gelatine, Magnesiumstearat, Natriumdodecylsulfat, Siliciumdioxid, Farbstoffe E 132, E 171, zusätzl. f. Levopar 62,5 mg/-125 mg: Farbstoff E 172.

Levopar® 62,5 Elderly Dosage

1 Kps. entspr. 0,01 BE/0,01 BE/0,03 BE.

Levopar® 62,5 Precautions, Reactions and Contraindications

Levopar® 62,5 Special Precautions

Levopar® 62,5 Special Precautions

Pat

Related Drugs - Neurological Disorders

Back to top